key: cord-0743537-v7xbnfg9
authors: Liu, Haiting; Shang, Xueling; Chen, Sai; Li, Tie; Zhang, Junhua
title: Cautions on the laboratory indicators of COVID‐19 patients on and during admission
date: 2021-05-05
journal: J Clin Lab Anal
DOI: 10.1002/jcla.23767
sha: 9c5af3f29b79bdfb861797a4b2849dd930e6c360
doc_id: 743537
cord_uid: v7xbnfg9

BACKGROUND: Different disease severities of COVID‐19 patients could be reflected on clinical laboratory findings. METHODS: In this single‐centered retrospective study, demographic, clinical, and laboratory indicators on and during admission were compared among 74 participants with mild, moderate, critical severe, or severe classification. Risk factors associated with disease severity were analyzed by multivariate analyses. The AUC and 95% CI of the ROC curve were calculated. RESULTS: The most common manifestations of these patients were fever and cough. Critical severe or severe group owned the longest length of stay (23 (19,31), p < 0.001). After multivariate logistic regression, independent influence factors on admission for severity of disease were CK‐MB (OR 0.674; 95% CI 0.489–0.928; p = 0.016), LDH (OR 1.111 or 1.107; 95% CI 1.026–1.204 or 1.022–1.199; p = 0.009 or 0.013), normal T‐BIL (OR 4.58 × 10(−8); 95% CI 3.05 × 10(−9)–6.88 × 10(−7); p < 0.001), LYM% (OR 0.008; 95% CI 0–0.602; p = 0.029), and normal ESR (OR 0.016; 95% CI 0–0.498; p = 0.019). Factors during hospitalization were normal T‐BIL (OR 8.56 × 10(−9); 95% CI 8.30 × 10(−10)–8.83 × 10(−8); p < 0.001), LYM (OR 0.068; 95% CI 0.005–0.934; p = 0.044), albumin (OR 0.565; 95% CI 0.327–0.977; p = 0.041), and normal NEU% (OR 0.013; 95% CI 0.000–0.967; p = 0.048). Combined indicators of AUC were 0.860 (LYM, LDH, and normal ESR on admission, p < 0.001) and 0.750 (CK‐MB, LDH, and normal T‐BIL during hospitalization, p = 0.020) when predicting for severe or critical severe patients. CONCLUSION: To pay close attention to the progression of COVID‐19 and take measures promptly, we should be cautious of the laboratory indicators when patients on admission especially CK‐MB, LDH, LYM%, T‐BIL as well as ESR; and T‐BIL, LYM, albumin, NEU% with the process of disease.

Since December 2019, a number of patients with unexplained pneumonia had been reported in Wuhan, China. Later in January 2020, the pathogen was isolated to be a kind of novel coronavirus and named as 2019-nCoV. 1 The epidemic was initially found in mainland China; then, it spread rapidly and became a worldwide health concern. 2 Globally, as of June 1, 2020, there have been 6040 609 confirmed cases due to coronavirus disease 2019 , including 370 657 deaths, reported to WHO (https:// covid 19.who.int/). Confirmed patients mainly present with fever, dry cough, fatigue, dyspnea, and bilateral ground-glass opacities on chest CT scans, which are likely to the features of SARS-CoV and MERS-CoV infections. Some exhibit nausea and vomiting. [3] [4] [5] [6] According to the latest guidance issued by National Health This disease may lead to potential damage to vital organs such as lung, liver, kidney, and heart with a mechanism analogous to the SARS coronavirus involving ACE2, which could be reflected on many aspects including laboratory findings, manifestations, and radiological image. 7 Though there are numbers of reports related to COVID-19, most of the previous studies focused on epidemiology and clinical characteristics of patients. Reported studies have explored risk factors associated with clinical outcomes, such as laboratory findings, immunological features, cytokine storm, and liver biochemistries. [8] [9] [10] [11] However, some of those researches commonly conducted on critically ill cases with 2019-nCoV infection; others payed more attention to mortality or monitoring rather than predicting the severity of disease in current patients. [12] [13] [14] Few studies have conducted multivariable regression to help identify the dependent risk factors of disease severity during the different periods of admission. 15 In order to investigate the possible association between laboratory indicators and disease severity, we conducted a singlecentered, retrospective study in Yueyang First People's Hospital, Hunan province, China. Here, we present detailed laboratory results of all hospitalized COVID-19 patients and analyze risk factors when patients on and during admission via multivariate logistic regression.

This retrospective study was conducted in Yueyang First People's Hospital, Hunan province, China. Patients with confirmed COVID-19 during the period from January 2020 to March 15, 2020 , were enrolled in our study. During the study period, there were 83 confirmed COVID-19 cases in total and 74 were enrolled finally.

Inclusion criteria were as follows: The patients were confirmed with COVID-19. The diagnostic criteria of COVID-19 refer to the latest guidance issued by National Health Commission of the People's Republic of China (NHC China), including fever/or respiratory symptoms; pulmonary CT image features: multiple lobular shadows or ground-glass shadows; and the novel coronavirus nucleic acid of respiratory specimens is positive.

Exclusion criteria were as follows: Patients with incomplete laboratory indicators were excluded. After that only qualified variables were entered into a multivariate logistic regression to identify independent risk factors for disease severity. The AUC and the 95% confidence interval of the receiver operator characteristic (ROC) curve were calculated using the predicted probability of the severity of COVID-19. p < 0.05 was considered statistical significance.

The study was approved by the Ethics Committees from Xiangya Third Hospital, Central South University (2019-S000).

During the study period, 83 hospitalized cases with confirmed COVID-19 were identified. Nine patients with incomplete laboratory results were excluded, leaving 74 for final analysis in our study ( Figure 1 ).

The baseline characteristics of participants were shown in (44.0%) critical severe or severe patients manifested anhelation (p = 0.036). The length of stay is significantly different among groups (p < 0.001) and patients who were more seriously ill stayed longer.

Blood routine, as well as clinical chemistry indicators, coagulation, and other inflammation indicators were obtained. We performed univariate analyses to determine indexes that could be further enrolled in multivariate logistic regression analysis. Indicators with statistically significance on admission are depicted in Table 2 , and more details are shown in supplements (Tables S1-S5). We investigated the relationship between the first-time laboratory examination indicators when patients on admission and disease severity, based on the univariate analyses above and consideration of professional evidence. Multivariate logistic regression analysis was performed to identify those variables that were independently associated with severity of patients. Results are shown in Table 3 . 

The most abnormal indicators with statistical significance during admission are shown in Table 4 , and more details are shown in supplements (Tables S8-S12). The levels of LYM, NEU%, LYM%, albumin, ALT, and LDH have statistical significance among three groups.

Proportion of cases with decreased LYM and albumin, elevated NEU%, ALT, T-BIL, and Mb also show statistical differences. We find that LYM and LYM% levels are much higher in mild patients than oth- Based on the univariate analyses, collinearity diagnosis, and test of parallel lines, as well as consideration of professional evidence, we identified several variables that could be enrolled in further study ( Figure S2 , Tables S13,S14.

In this single-center retrospective study, we found that several lab- 6 Other studies found that lymphocyte decreasing occurred while WBC counts remained normal or not. 16, 17 In a logistic regression analysis, peripheral blood lymphocyte count <0.8 × 10 9 /L was found to be a risk factor for mortality of pneumonia patients. 18 Similarly, in our univariate analyses whether on admission or during hospitalization, we found that LYM and LYM% level went lower with a more serious illness situation. But the WBC counts in our study were in a normal range (Table S1 ,S8). According to laboratory findings, LYM level in most patients was reduced, which is result from the possible role of ACE in hematopoiesis regulating. 19 Angiotensinconverting enzyme 2 (ACE2) is able to bind with the receptor-binding domain of SARS-CoV-2 spike protein. 20, 21 Researchers proposed that COVID-19 could lead to ACE2 reduction and increasing ACE expression in myeloid precursors, then worsen immune response and T-cell consumption. 17 We found difference in the most abnormal NEU% level among groups (p = 0.009), and elevated NEU% proportion was higher in severe cases. Multivariate logistic regression showed that normal NEU% was an independent influence factor for disease severity (OR 0.013; 95%CI 0.000-0.967; p = 0.048). This is consistent with other studies. Huang et al. 6 reported that elevated NEU% was more frequent with the disease progression. Neutrophil counts were significantly higher in severe cases than moderate cases. 22 One systematic review described that neutrophil counts could be used as a predictor for severe COVID-19. 23 Furthermore, leukocytosis and neutrophilia are hallmarks of acute infection, and lung infiltration of neutrophils was found in patient succumbed to COVID-19. 24 These neutrophil changes may due to the infiltration mechanistically regulated by ACE2. 25 Researchers observed that ACE2 negatively regulates AngII, thus increasing vascular permeability, lung edema, and neutrophil infiltration. 26 Liver injury is frequent in COVID-19 patients and manifest various degrees of function abnormalities. 27 In the present analysis, we found albumin and elevated T-BIL during hospitalization to be independent influence factors for disease severity. Mild patients had higher albumin, and it went lower with the aggravation of infection. Moderate and severe cases showed more proportion of elevated T-BIL than mild group. This is supported by the study by Qingxian Cai et al., 28 who found cases with abnormal liver tests were at higher risk of progressing to severe pneumonia. They mentioned that drug usage was the most important influence factor for liver 

damage after admission. Another study reported that using serum albumin might be helpful to identify patients at higher risk of death.

Hypoalbuminemia is a feature of acute and chronic inflammation, and albumin may protect against the cytokine storm and anticoagulant, thus giving a possible explanation for this relationship. 29 Yang et al. 30 reported that SARS-CoV could cause direct cytopathic liver injury which means direct viral effect on organ. One study showed that SARS-CoV-2 might directly bind to ACE2-positive cholangiocytes and cause liver damage. 27 However, we did not find other obvious liver indicator changes like other studies, including GGT and zymogram. 31 We only found that ALT level was statistically significant in univariate analysis but generally remained in a normal range.

Possible explanation is that the participants were slightly different among researches. Some of them analyzed deceased or ICU cases, while in our study we chose the current cases. Besides, various sample sizes, pre-existing diseases and drugs could also be the possible reasons.

The LDH level when on and during admission elevated with the severity increasing, and critical severe or severe patients had the highest results. Logistic regression analysis indicated that LDH was a relevant risk factor for infection severity. Similarly, Guang Chen et al. 11 found LDH was significantly higher in more severe cases.

Davide Ferrari et al. 32 analyzed 207 emergency participants and found a strong association for LDH with pandemic. Another study revealed that most COVID-19 patients had abnormal myocardial zymogram, 13% cases with elevation of creatine kinase and 76% LDH. 5

In our univariate analyses, both CK-MB and LDH were statistically different among groups and had the same increasing trend when disease worsen. But later multivariate analysis showed opposite trend between CK-MB (OR = 0.674) and LDH (OR > 1). Taking that 13%

vs. 76% elevation into consideration, LDH seems to be a more credible indicator. We speculated that this contradictory result emerged when the two factors discussed from respectively to simultaneously, possibly owing to statistics and it was only analyzed theoretically.

Anyway, COVID-19 patients have a high prevalence of cardiovascular disease. Over 7% of them experience myocardial injury from the infection. 33 ACE2 is highly expressed in the heart as well, making it possible to be directly affected by the coronavirus. Cardiac damage can also result from the associated cytokine storm manifested by elevated LDH. 34 However, when using LDH as a reminding factor for disease severity, its organ specificity should be taken into consideration and exclude other organ damage first.

We found that ESR elevation on admission is possibly related to the severity and normal ESR is an independent influence factor (OR 0.016; 95%CI 0-0.498; p = 0.019) for disease progression. It was predictor of death and associated with thrombosis in another study. Interestingly, we did not observe differences in other coagulation and inflammation indicators among groups including D-dimer, which has been reported frequently. Al-Samkari et al. 35 found that elevations in D-dimer on admission predicted critical illness. Other studies showed significant D-dimer elevation in more serious patients, and ICU patients had higher D-dimer level on admission than non-ICU. 6 herbal medications, and so on could induce liver injury during treatment. 28 Severe patients usually required more treatment, causing the albumin level to worsen than when untreated. Difference among groups became more obvious and significant. As for normal NEU%, peripheral blood lymphocytes progressively decrease in severe COVID-19 cases, 41 making NEU% relatively elevate. NEU counts could also be hallmark of acute infection and higher during progression of disease. 22, 24 Therefore, the emergence of the predictive value of albumin and normal NEU% may indicate the liver injury, medication, or progression of lymphocytopenia.

Our study has several limitations. Considering its retrospective design, possible information bias was inherently present in this single-center study. Moreover, only laboratory tests included may not represent the patient condition properly, and clinical manifestations and radiologic images also could be involved to identify disease severity. And because of the small sample size, we need to further collect more available data to investigate the association between laboratory indexes and disease severity among different patients.

In conclusion, to predict the progression of disease severity and take measures promptly, when the patients on admission, we should be cautious of the blood routine and biochemical indicators especially 

We extend our gratitude to the colleagues in the department of laboratory medicine, Yueyang First People's Hospital, Yueyang, Hunan,

China, for data collection.

The authors declare no conflict of interest or personal relationships that could have appeared to influence the work reported in this paper.

J. Zhang involved in conception, design, or planning of the study; J.

Zhang, S. Chen, and T. Li involved in acquisition of the data; X. Shang, S. Chen, and H. Liu curated and analyzed the data; X. Shang and H.

Liu drafted the manuscript; J. Zhang critically reviewed and edited the manuscript.

The data that support the findings of this study are available from Yueyang First People's Hospital, but restrictions apply to the availability of these data, which were used under license for the current study, and so are not publicly available. Data are, however, available from the authors upon reasonable request and with permission of Yueyang First People's Hospital.

Xueling Shang https://orcid.org/0000-0002-9395-7340

A new coronavirus associated with human respiratory disease in China

Estimates of the severity of coronavirus disease 2019: a model-based analysis

A major outbreak of severe acute respiratory syndrome in Hong Kong

Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study

Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study

Clinical features of patients infected with 2019 novel coronavirus in Wuhan

Clinical and epidemiological features of 36 children with coronavirus disease 2019 (COVID-19) in Zhejiang, China: an observational cohort study

Risk factors associated with clinical outcomes in 323 COVID-19 hospitalized patients in Wuhan, China

Plasma IP-10 and MCP-3 levels are highly associated with disease severity and predict the progression of COVID-19

Liver biochemistries in hospitalized patients with COVID-19

Clinical and immunological features of severe and moderate coronavirus disease 2019

The role of interleukin-6 in monitoring severe case of coronavirus disease 2019

Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a singlecentered, retrospective, observational study

Clinical characteristics and outcomes of hospitalised patients with COVID-19 treated in Hubei (epicenter) and outside Hubei (non-epicenter): a Nationwide Analysis of China

Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease

Hematologic parameters in patients with COVID-19 infection

Hematological findings in coronavirus disease 2019: indications of progression of disease

Clinical features predicting mortality risk in patients with viral pneumonia: the MuLBSTA score

Local bone marrow renin-angiotensin system in primitive, definitive and neoplastic haematopoiesis

Emergence of a novel coronavirus, severe acute respiratory syndrome coronavirus 2: biology and therapeutic options

Systematic comparison of two animal-tohuman transmitted human coronaviruses: SARS-CoV-2 and SARS-CoV

Neutrophil-to-lymphocyte ratio predicts critical illness patients with 2019 coronavirus disease in the early stage

Prediction models for diagnosis and prognosis of covid-19 infection: systematic review and critical appraisal

Targeting potential drivers of COVID-19: Neutrophil extracellular traps

Neutrophils and neutrophil extracellular traps drive necroinflammation in COVID-19

Angiotensin-converting enzyme 2 protects from severe acute lung failure

Liver injury in COVID-19: the current evidence

COVID-19: abnormal liver function tests

Is albumin predictor of mortality in COVID-19? Antioxid Redox Signal

Clinical characteristics and mechanism of liver damage in patients with severe acute respiratory syndrome

Liver injury during highly pathogenic human coronavirus infections

Routine blood tests as a potential diagnostic tool for COVID-19

COVID-19 and cardiovascular disease

Angiotensin-Converting Enzyme 2 (ACE2) is a key modulator of the renin angiotensin system in health and disease

COVID-19 and coagulation: bleeding and thrombotic manifestations of SARS-CoV-2 infection

Laboratory abnormalities in patients with COVID-2019 infection

Diagnosis and treatment protocol for novel coronavirus pneumonia (Trial Version 7)

Hematological findings and complications of COVID-19

The biochemical and clinical perspectives of lactate dehydrogenase: an enzyme of active metabolism

Usefulness of lactate dehydrogenase and its isoenzymes as indicators of lung damage or inflammation

Biomarkers associated with COVID-19 disease progression

Additional supporting information may be found online in the Supporting Information section